Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 59

1.

Impact of Gentamicin-Loaded Bone Graft on Defect Healing in a Sheep Model.

Beuttel E, Bormann N, Pobloth AM, Duda GN, Wildemann B.

Materials (Basel). 2019 Apr 4;12(7). pii: E1116. doi: 10.3390/ma12071116.

2.

The effect of autologous platelet rich plasma on tenocytes of the human rotator cuff.

Pauly S, Klatte-Schulz F, Stahnke K, Scheibel M, Wildemann B.

BMC Musculoskelet Disord. 2018 Nov 30;19(1):422. doi: 10.1186/s12891-018-2339-5.

3.

Bone morphogenetic proteins - 7 and - 2 in the treatment of delayed osseous union secondary to bacterial osteitis in a rat model.

Helbig L, Omlor GW, Ivanova A, Guehring T, Sonntag R, Kretzer JP, Minkwitz S, Wildemann B, Schmidmaier G.

BMC Musculoskelet Disord. 2018 Jul 27;19(1):261. doi: 10.1186/s12891-018-2203-7.

4.

Different Achilles Tendon Pathologies Show Distinct Histological and Molecular Characteristics.

Klatte-Schulz F, Minkwitz S, Schmock A, Bormann N, Kurtoglu A, Tsitsilonis S, Manegold S, Wildemann B.

Int J Mol Sci. 2018 Jan 30;19(2). pii: E404. doi: 10.3390/ijms19020404.

5.

Comparative Analysis of Different Platelet Lysates and Platelet Rich Preparations to Stimulate Tendon Cell Biology: An In Vitro Study.

Klatte-Schulz F, Schmidt T, Uckert M, Scheffler S, Kalus U, Rojewski M, Schrezenmeier H, Pruss A, Wildemann B.

Int J Mol Sci. 2018 Jan 10;19(1). pii: E212. doi: 10.3390/ijms19010212.

6.

Time-Dependent Alterations of MMPs, TIMPs and Tendon Structure in Human Achilles Tendons after Acute Rupture.

Minkwitz S, Schmock A, Kurtoglu A, Tsitsilonis S, Manegold S, Wildemann B, Klatte-Schulz F.

Int J Mol Sci. 2017 Oct 20;18(10). pii: E2199. doi: 10.3390/ijms18102199.

7.

New insights into tenocyte-immune cell interplay in an in vitro model of inflammation.

Stolk M, Klatte-Schulz F, Schmock A, Minkwitz S, Wildemann B, Seifert M.

Sci Rep. 2017 Aug 29;7(1):9801. doi: 10.1038/s41598-017-09875-x.

8.

* Demineralized Bone Matrix as a Carrier for Bone Morphogenetic Protein-2: Burst Release Combined with Long-Term Binding and Osteoinductive Activity Evaluated In Vitro and In Vivo.

Huber E, Pobloth AM, Bormann N, Kolarczik N, Schmidt-Bleek K, Schell H, Schwabe P, Duda GN, Wildemann B.

Tissue Eng Part A. 2017 Dec;23(23-24):1321-1330. doi: 10.1089/ten.TEA.2017.0005. Epub 2017 Apr 28.

PMID:
28351338
9.

An investigation of BMP-7 mediated alterations to BMP signalling components in human tenocyte-like cells.

Klatte-Schulz F, Giese G, Differ C, Minkwitz S, Ruschke K, Puts R, Knaus P, Wildemann B.

Sci Rep. 2016 Jul 11;6:29703. doi: 10.1038/srep29703.

10.

Testing of antibiotic releasing implant coatings to fight bacteria in combat-associated osteomyelitis - an in-vitro study.

Back DA, Bormann N, Calafi A, Zech J, Garbe LA, Müller M, Willy C, Schmidmaier G, Wildemann B.

Int Orthop. 2016 May;40(5):1039-47. doi: 10.1007/s00264-016-3142-2. Epub 2016 Feb 23.

PMID:
26907873
11.

RIA fractions contain mesenchymal stroma cells with high osteogenic potency.

Kuehlfluck P, Moghaddam A, Helbig L, Child C, Wildemann B, Schmidmaier G; HTRG-Heidelberg Trauma Research Group.

Injury. 2015 Dec;46 Suppl 8:S23-32. doi: 10.1016/S0020-1383(15)30051-6.

PMID:
26747914
12.

Do Matrix Metalloproteases and Tissue Inhibitors of Metalloproteases in Tenocytes of the Rotator Cuff Differ with Varying Donor Characteristics?

Klatte-Schulz F, Aleyt T, Pauly S, Geißler S, Gerhardt C, Scheibel M, Wildemann B.

Int J Mol Sci. 2015 Jun 9;16(6):13141-57. doi: 10.3390/ijms160613141.

13.

Longitudinal analysis of osteogenic and angiogenic signaling factors in healing models mimicking atrophic and hypertrophic non-unions in rats.

Minkwitz S, Faßbender M, Kronbach Z, Wildemann B.

PLoS One. 2015 Apr 24;10(4):e0124217. doi: 10.1371/journal.pone.0124217. eCollection 2015.

14.

Do patient age and sex influence tendon cell biology and clinical/radiographic outcomes after rotator cuff repair?

Pauly S, Stahnke K, Klatte-Schulz F, Wildemann B, Scheibel M, Greiner S.

Am J Sports Med. 2015 Mar;43(3):549-56. doi: 10.1177/0363546514562552. Epub 2015 Jan 8.

PMID:
25573392
15.

Signaling pathway STAT1 is strongly activated by IFN-β in the pathogenesis of osteoporosis.

Seeliger C, Schyschka L, Kronbach Z, Wottge A, van Griensven M, Wildemann B, Vester H.

Eur J Med Res. 2015 Jan 7;20:1. doi: 10.1186/s40001-014-0074-4.

16.

A pilot study investigating the histology and growth factor content of human non-union tissue.

Schwabe P, Simon P, Kronbach Z, Schmidmaier G, Wildemann B.

Int Orthop. 2014 Dec;38(12):2623-9. doi: 10.1007/s00264-014-2496-6. Epub 2014 Aug 27.

PMID:
25159009
17.

Stimulation of bone healing by sustained bone morphogenetic protein 2 (BMP-2) delivery.

Faßbender M, Minkwitz S, Strobel C, Schmidmaier G, Wildemann B.

Int J Mol Sci. 2014 May 14;15(5):8539-52. doi: 10.3390/ijms15058539.

18.

Efficacy of two different demineralised bone matrix grafts to promote bone healing in a critical-size-defect: a radiological, histological and histomorphometric study in rat femurs.

Fassbender M, Minkwitz S, Thiele M, Wildemann B.

Int Orthop. 2014 Sep;38(9):1963-9. doi: 10.1007/s00264-014-2321-2. Epub 2014 Apr 9.

PMID:
24714881
19.

Whither advanced therapy medicinal products?

Smith MD, Brune JC, Wildemann B, Pruss A.

Transfus Med Hemother. 2013 Dec;40(6):449-52. doi: 10.1159/000356514. Epub 2013 Nov 12. No abstract available.

20.

Slight changes in the mechanical stimulation affects osteoblast- and osteoclast-like cells in co-culture.

Kadow-Romacker A, Duda GN, Bormann N, Schmidmaier G, Wildemann B.

Transfus Med Hemother. 2013 Dec;40(6):441-7. doi: 10.1159/000356284. Epub 2013 Oct 27.

Supplemental Content

Loading ...
Support Center